28 research outputs found
Diagnostic testing practices for diarrhoeal cases in South African public hospitals
BACKGROUND : Stool samples submitted for diagnostic testing represent a proportion of diarrhoeal cases seeking
healthcare, and an even smaller proportion of diarrhoeal cases in the community. Despite this, surveillance relies
heavily on these laboratory results. This study described diarrhoeal diagnostic practices and aetiological agents of
diarrhoea in patients admitted to three South African public hospitals in order to understand biases in surveillance
data, and inform guidelines, diagnostic and laboratory practices to improve clinical management.
METHODS : A doctorsâ survey was conducted to determine sample submission, diarrhoeal treatment and barriers to
submitting samples for testing. Results for all samples submitted for routine diagnostics were obtained from the NHLS
Central Data Warehouse. An enhanced surveillance study enrolled patients with acute diarrhoea at the same hospitals
over the same period. Differences between routine culture results and molecular testing from the surveillance study
were described.
RESULTS : Stool samples were seldom submitted for diagnostic testing (median of 10% of admitted cases). Current
diagnostic guidelines were not useful, hence most doctors (75.1%) relied on their own clinical judgement or judgement
of a senior clinician. Although most doctors (90.3%) agreed that diagnostics were helpful for clinical management,
they reported patients being unwilling to provide samples and long laboratory turnaround times. Routine
diagnostic data represent cases with chronic diarrhoea and dysentery since doctors are most likely to submit specimens
for these cases. Pathogen yield (number of pathogens detected for samples tested for specific pathogens)
was significantly higher in the surveillance study, which used molecular methods, than through routine diagnostic
services (73.3% versus 8.2%, p < 0.001), including for viruses (48.9% versus 2.6%, p < 0.001), bacteria (40.1% versus 2.2%,
p < 0.001) and parasites (16.2% versus 3.6%, p < 0.001). Despite viruses being commonly detected in the surveillance
study, viral testing was seldom requested in routine diagnostic investigations.
CONCLUSIONS : Comprehensive diagnostic and treatment guidelines are required for diarrhoeal diseases. These guidelines
should be informed by local epidemiological data, where diagnostic testing is reserved for cases most likely to
benefit from specific treatment. Optimisation of current diagnostic processes and methods are required for these
cases, specifically in terms of minimising turnaround times while maximising diagnostic acumen.The ANDEMIA study was supported by the German Federal Ministry of Education and Research.http://www.biomedcentral.com/bmcinfectdisam2023Medical VirologyPaediatrics and Child Healt
Identifying gaps in hand hygiene practice to support tailored target audience messaging in Soweto : a cross-sectional community survey
Effective risk communication is essential for outbreak mitigation, as recently highlighted
during the coronavirus disease 2019 (COVID-19) pandemic. Hand hygiene is one of the
proposed public health interventions to protect against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) acquisition and transmission along with social distancing,
improved ventilation, environmental cleaning, and wearing of masks. Improving hand
hygiene practices in the community requires an understanding of the socio-behavioural
context. This cross-sectional community survey in Soweto identified gaps in hand hygiene,
which can inform appropriate messaging at the community level. Only 42% of survey
respondents practiced adequate hand hygiene. Tailored educational messaging should be
targeted at young adults in particular, and the importance of soap for hand hygiene must be
emphasised for all age groups. Risk communication should expand to focus on preventing
multiple infectious diseases during and beyond the COVID-19 pandemic.GlaxoSmithKline and the German Federal Ministry of Education and Research. The CHAMPS programme is funded by the Bill & Melinda Gates Foundation.https://sajid.co.za/index.php/sajiddm2022Medical Virolog
Diarrhoeal diseases in Soweto, South Africa, 2020 : a cross-sectional community survey
BACKGROUND : In South Africa, there are limited data on the burden of diarrhoea at a community level, specifically in
older children and adults. This community survey estimated rates of and factors associated with diarrhoea across all
ages and determined the proportion of cases presenting to healthcare facilities.
METHODS : Households were enrolled from an existing urban health and demographic surveillance site. A household
representative was interviewed to determine associated factors and occurrence of diarrhoea in the household, for
all household members, in the past 2 weeks (including symptoms and health seeking behaviour). Diarrhoeal rate of
any severity was calculated for 15 years age groups. Factors associated with diarrhoea
and health seeking behaviour were investigated using binomial logistic regression.
RESULTS : Diarrhoeal rate among respondents (2.5 episodes/person-year (95% CI, 1.8â3.5)) was significantly higher
than for other household members (1.0 episodes/person-year (95% CI, 0.8â1.4); IRR = 2.4 (95% CI, 1.5â3.7) p < 0.001).
Diarrhoeal rates were similar between age groups, however younger children (< 5 years) were more likely to
present to healthcare facilities than adults (OR = 5.9 (95% CI, 1.1â31.4), p = 0.039). Oral rehydration solution was used
in 44.8% of cases. Having a child between 5 and 15 years in the household was associated with diarrhoea (OR = 2.3
(95% CI, 1.3â3.9), p = 0.003) and, while 26.4% of cases sought healthcare, only 4.6% were hospitalised and only 3.4%
of cases had a stool specimen collected. While the majority of cases were mild, 13.8% of cases felt they required
healthcare but were unable to access it.
CONCLUSION : Diarrhoeal rate was high across all age groups in this community; however, older children and adults
were less likely to present to healthcare, and are therefore underrepresented through facility-based clinical
surveillance. Current diarrhoeal surveillance represents a fraction of the overall cases occurring in the community.SUPPLEMENTARY MATERIAL: FIGURE S1. Health seeking for reported diarrhoeal episodes. TABLE S1. Factors associated with ORS knowledge.This work was supported by GlaxoSmithKline [E-Track 200238] and the
German Federal Ministry of Education and Research [grant number
81203616] to SLJ. The CHAMPS program is funded by the Bill & Melinda
Gates Foundation (Grant OPP1126780).http://www.biomedcentral.com/bmcpublichealtham2022Medical Virolog
People are essential to linking biodiversity data
People are one of the best known and most stable entities in the biodiversity knowledge graph. The wealth of public information associated with people and the ability to identify them uniquely open up the possibility to make more use of these data in biodiversity science. Person data are almost always associated with entities such as specimens, molecular sequences, taxonomic names, observations, images, traits and publications. For example, the digitization and the aggregation of specimen data from museums and herbaria allow us to view a scientistâs specimen collecting in conjunction with the whole corpus of their works. However, the metadata of these entities are also useful in validating data, integrating data across collections and institutional databases and can be the basis of future research into biodiversity and science. In addition, the ability to reliably credit collectors for their work has the potential to change the incentive structure to promote improved curation and maintenance of natural history collections
The African Network for Improved Diagnostics, Epidemiology and Management of common infectious Agents
In sub-Saharan Africa, acute respiratory infections (ARI), acute gastrointestinal infections (GI) and acute febrile disease of unknown cause (AFDUC) have a large disease burden, especially among children, while respective aetiologies often remain unresolved. The need for robust infectious disease surveillance to detect emerging pathogens along with common human pathogens has been highlighted by the ongoing novel coronavirus disease2019 (COVID-19) pandemic. The African Network for Improved Diagnostics, Epidemiology and Management of Common Infectious Agents (ANDEMIA) is a sentinel surveillance study on the aetiology and clinical characteristics of ARI, GI and AFDUC in sub-Saharan Africa.Peer Reviewe
Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics
Osteosarcoma (OSA) is a rare cancer in people. However OSA incidence rates in dogs are 27 times higher than in people. Prognosis in both species is poor, with five year osteosarcoma survival rates in people not having improved in decades. For dogs, one year survival rates are only around ~45%. Improved and novel treatment regimens are urgently required to improve survival in both humans and dogs with OSA. Utilising information from genetic studies could assist in this in both species, with the higher incidence rates in dogs contributing to the dog population being a good model of human disease. This review compares the clinical characteristics, gross morphology and histopathology, aetiology, epidemiology, and genetics of canine and human osteosarcoma. Finally, the current position of canine osteosarcoma genetic research is discussed and areas for additional work within the canine population are identified
Recommended from our members
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (nâ=â143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (nâ=â152), or no hydrocortisone (nâ=â108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (nâ=â137), shock-dependent (nâ=â146), and no (nâ=â101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707
The Molecular Origin and Taxonomy of Mucinous Ovarian Carcinoma
Mucinous ovarian carcinoma (MOC) is a unique subtype of ovarian cancer with an uncertain etiology, including whether it genuinely arises at the ovary or is metastatic disease from other organs. In addition, the molecular drivers of invasive progression, high-grade and metastatic disease are poorly defined. We perform genetic analysis of MOC across all histological grades, including benign and borderline mucinous ovarian tumors, and compare these to tumors from other potential extra-ovarian sites of origin. Here we show that MOC is distinct from tumors from other sites and supports a progressive model of evolution from borderline precursors to high-grade invasive MOC. Key drivers of progression identified are TP53 mutation and copy number aberrations, including a notable amplicon on 9p13. High copy number aberration burden is associated with worse prognosis in MOC. Our data conclusively demonstrate that MOC arise from benign and borderline precursors at the ovary and are not extra-ovarian metastases
Increasing frailty is associated with higher prevalence and reduced recognition of delirium in older hospitalised inpatients: results of a multi-centre study
Purpose:
Delirium is a neuropsychiatric disorder delineated by an acute change in cognition, attention, and consciousness. It is common, particularly in older adults, but poorly recognised. Frailty is the accumulation of deficits conferring an increased risk of adverse outcomes. We set out to determine how severity of frailty, as measured using the CFS, affected delirium rates, and recognition in hospitalised older people in the United Kingdom.
Methods:
Adults over 65 years were included in an observational multi-centre audit across UK hospitals, two prospective rounds, and one retrospective note review. Clinical Frailty Scale (CFS), delirium status, and 30-day outcomes were recorded.
Results:
The overall prevalence of delirium was 16.3% (483). Patients with delirium were more frail than patients without delirium (median CFS 6 vs 4). The risk of delirium was greater with increasing frailty [OR 2.9 (1.8â4.6) in CFS 4 vs 1â3; OR 12.4 (6.2â24.5) in CFS 8 vs 1â3]. Higher CFS was associated with reduced recognition of delirium (OR of 0.7 (0.3â1.9) in CFS 4 compared to 0.2 (0.1â0.7) in CFS 8). These risks were both independent of age and dementia.
Conclusion:
We have demonstrated an incremental increase in risk of delirium with increasing frailty. This has important clinical implications, suggesting that frailty may provide a more nuanced measure of vulnerability to delirium and poor outcomes. However, the most frail patients are least likely to have their delirium diagnosed and there is a significant lack of research into the underlying pathophysiology of both of these common geriatric syndromes